AGI-14100

• Description :

  AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.

• CAS Number :

  1448346-43-7

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  599.96

• Molecular Formula :

  C29H22ClF4N5O3

• Notes :

  Research use only, not for human use.

• Receptor :

  Dehydrogenase